Related Experiment Video

Updated: May 20, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic

K Nagai, H Fujiwara, T Ochi

    Blood Cancer Journal
    |July 26, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
    09:29

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

    Published on: February 1, 2013

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
    06:51

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

    Published on: December 17, 2019

    Related Experiment Videos

    Last Updated: May 20, 2026

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
    10:02

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

    Published on: January 6, 2023

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
    09:29

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

    Published on: February 1, 2013

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
    06:51

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

    Published on: December 17, 2019

    Related Concept Videos

    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

    Articles linked to this work by shared authors, journal, and citation graph.

    Gut microbiota development of preterm infants hospitalised in intensive care units.

    Beneficial microbes·2019

    Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.

    Blood cancer journal·2016

    Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.

    Leukemia·2014

    Fatal hepatic hemorrhage by peliosis hepatis in X-linked myotubular myopathy: a case report.

    Neuromuscular disorders : NMD·2013

    Hepatic artery reconstruction prevents ischemic graft injury, inhibits graft rejection, and mediates long-term graft acceptance in rat liver transplantation.

    Transplantation proceedings·2013

    Chronic antibody-mediated responses may mediate chronic rejection in rat orthotopic liver transplantation.

    Transplantation proceedings·2013

    Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial.

    Blood cancer journal·2026

    Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.

    Blood cancer journal·2026

    A multicentre phase III clinical trial of dual-epigenetic therapy plus CHOP compared with CHOP in previously untreated patients with peripheral T-cell lymphoma.

    Blood cancer journal·2026

    Treatment patterns and outcomes for second-line therapy in large B-cell lymphoma: results from the LEO CReWE study.

    Blood cancer journal·2026

    A myeloid-dormant metabolic transcriptome identifies a poor-prognosis subgroup in hyperdiploid multiple myeloma with targetable vulnerabilities.

    Blood cancer journal·2026

    Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

    Blood cancer journal·2026

    Intravenous leiomyomatosis with marked edematous degeneration mimicking IVC thrombus: A case report.

    Radiology case reports·2026

    Mirikizumab is associated with improvements in bowel urgency and quality of life in moderately-to-severely active ulcerative colitis: 28-week phase 3b results from the LUCENT-URGE trial.

    Crohn's & colitis 360·2026

    Functional Immunopeptidomics by Characterizing Immunopeptides Against HLAs, TCRs, and Antibodies.

    Research square·2026

    Belimumab With Rituximab for the Treatment of Primary Membranous Nephropathy.

    Kidney international reports·2026

    Programmable antigen-presenting scaffolds expand rare tumor-antigen-specific T cells from peripheral blood.

    bioRxiv : the preprint server for biology·2026

    Islet size and spatial organization govern endocrine cell composition throughout the human pancreas.

    bioRxiv : the preprint server for biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us